<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>SARS-CoV-2 Study</title>
  <link href="./image/covid.png"font" />
  <link rel="stylesheet" href="main.css">

  
</head>
<body>

  <div class="header">
    CORRESPONDENCE
    <span class="label">| Nov 13, 2024 | <span class="free">FREE</span></span>
  </div>

  <div class="image">
    <img src="image/chart.png" alt="" />
  </div>  

  <h1>Activity of Research-Grade
  <br>Pemivibart against SARS-CoV-2
  <br>Sublineages</h1>
  <h2>Q. Wang and Others</h2>
  <p class="article-body">
    SARS-CoV-2 continues to evolve under immunologic pressure. A
    <br>synthesized version of pemivibart, an anti-SARS-CoV-2 monoclonal
    <br>antibody with recent emergency-use authorization, showed mixed
    <br>activity against emerging variants.
  </p>

  <p class="correction">
  <strong>Correction</strong>
  <a href="#">Pemivibart Activity against Recent SARS-CoV-2 JN.1
  <br>Sublineages</a>
  </p>

</body>
</html> 